Daniel Stark
4 Papers
9 Citations
Daniel Stark is an academic researcher. The author has contributed to research in topics: Internal medicine & Medicine. The author has an hindex of 2, co-authored 4 publications.
Chat about Author
Papers
A multicenter, dose-finding, phase 1b study of imatinib in combination with alpelisib as third-line treatment in patients with advanced gastrointestinal stromal tumor
Maria Abbondanza Pantaleo,Michael Heinrich,Antoine Italiano,Claudia Valverde,Patrick Schöffski,Giovanni Grignani,Anna K.L. Reyners,Sebastian Bauer,Peter Reichardt,Daniel Stark,Ghimja Berhanu,Ulrike Brandt,Tommaso Stefanelli,Hans Gelderblom +13 more
TL;DR: In this paper , the authors investigated the safety, tolerability and efficacy of alpelisib, a phosphatidylinositol 3-kinase inhibitor, used in combination with imatinib in patients with advanced GIST.
A multicenter, dose-finding, phase 1b study of imatinib in combination with alpelisib as third-line treatment in patients with advanced gastrointestinal stromal tumor
Maria Abbondanza Pantaleo,Michael Heinrich,Antoine Italiano,Claudia Valverde,Patrick Schöffski,Giovanni Grignani,Anna K.L. Reyners,Sebastian Bauer,Peter Reichardt,Daniel Stark,Ghimja Berhanu,Ulrike Brandt,Tommaso Stefanelli,Hans Gelderblom +13 more
TL;DR: In this paper , the authors investigated the safety, tolerability and efficacy of alpelisib, a phosphatidylinositol 3-kinase inhibitor, used in combination with imatinib in patients with advanced GIST.
GCT-03. MonoGerm: A proposed phase II trial of carboplatin or vinblastine monotherapy induction prior to radiotherapy for intracranial germinoma
Matthew J. Murray,John R. Apps,Anna Lawson,Laura Kirton,Andrew C. Peet,Theodoros N. Arvanitis,Lorna A Fern,Dipayan Mitra,Nicholas Coleman,Thankamma Ajithkumar,Brigitte Bison,Gareth J. Veal,Daniel Stark,Giovanni Montana,James Nicholson,Lucinda Billingham +15 more
TL;DR: It is established whether monotherapy is a treatment option in this setting, which may be practice-altering, and is associated with reduced toxicity and improved quality-of-life (QoL), evaluated through patient-reported-outcome-measures (PROMs).
1
Cancer, Fertility and Me: Developing and Testing a Novel Fertility Preservation Patient Decision Aid to Support Women at Risk of Losing Their Fertility Because of Cancer Treatment
Georgina Jones,Rachael H. Moss,Frances Darby,Neda Mahmoodi,Bob Phillips,Jane Hughes,Katharina Sophie Vogt,C. M. Greenfield,G Brauten-Smith,Jacqui Gath,Tonia Campbell,Daniel Stark,Galina Velikova,John A. Snowden,E Baskind,Mariano Mascerenhas,Daniel Yeomanson,Jonathan Skull,Sheila Lane,Hilary L. Bekker,Richard A. Anderson +20 more
TL;DR: A novel patient decision aid designed to support women to make fertility preservation treatment decisions around cancer diagnosis that helped them engage with decisions about fertility preservation, and make better informed, values-based care plans with oncology and fertility teams.